When Should You Take Melatonin? How Long It Takes to Work & Why Timing Matters
If you have ever taken melatonin and wondered whether you took it too early, too late, or expected it to work too fast, you are asking the right question. Melatonin is unusual because timing is part of its biology. It is not simply a sedative. It also signals the body clock, so the same dose taken at different times can produce different effects.
|
Quick Answer For Biogénique Melatonin 5 mg, follow the product label: adults take one tablet once per day, at or before bedtime. Health Canada’s current oral melatonin monograph gives a general ingredient-level direction of 30 to 60 minutes before bedtime, as needed. Research sometimes studies earlier timing for circadian-rhythm problems, but that is not a reason to move a licensed product’s timing on your own. The best timing depends on the sleep problem, formulation, dose and individual sleep-wake rhythm. |
What Time Should You Take Melatonin Before Bed?
Health Canada’s current oral melatonin monograph, updated December 19, 2025, is a useful starting point. For adults 18 and older, it supports several sleep-related uses and directs oral melatonin to be taken as needed, 30 to 60 minutes before bedtime. That is ingredient-level guidance for licensing and labelling; it is not identical to every individual product label.
Biogénique’s current 5 mg label is specific to this product. It directs adults to take one tablet once per day, at or before bedtime. That product-specific label takes priority when you use Biogénique Melatonin. Do not replace it with a timing rule pulled from a study or another brand with a different formulation.
How Long Does Melatonin Take to Work?
A common answer is “about 30 to 60 minutes,” but that needs context. In a 2016 pharmacokinetic study, 12 healthy male volunteers received 10 mg of oral melatonin. The average time to peak plasma concentration was about 41 minutes, while individual exposure varied substantially. That helps explain the common pre-bed window, but a blood-concentration peak is not a stopwatch for sleep onset.
A 2021 systematic review also found that formulation and dose can change melatonin pharmacokinetics. The authors could not recommend one specific formulation or profile for every sleep disorder. So “melatonin takes exactly 30 minutes to work” is too confident. Some people notice drowsiness sooner, some later, and some may not feel a dramatic sedating effect.
Why Can Timing Matter as Much as the Dose?
Melatonin has two relevant roles: a direct sleep-promoting effect and an ability to shift circadian timing. Those are related but not identical. For ordinary bedtime use, the goal is often to align the supplement with the planned sleep period. For a circadian problem such as delayed sleep-wake phase disorder, researchers may use a different schedule to move the internal clock.
A 2024 systematic review and dose-response meta-analysis of 26 double-blind randomized trials, covering 1,689 observations, found that administration timing influenced sleep outcomes. Its modelling suggested that earlier administration—around three hours before desired bedtime in the pooled data—might improve sleep-promoting effects compared with a commonly used 30-minute schedule. That is interesting science, not a new Biogénique instruction. Trials varied in population, dose, formulation and purpose, and Health Canada’s monograph still gives 30 to 60 minutes before bedtime as the general direction.
|
Important distinction A research protocol is not a product direction. Earlier schedules used in circadian research may be clinically interesting, but Biogénique users should follow the current product label unless a qualified health professional recommends otherwise. |
Bedtime Use vs. Circadian-Rhythm Timing
Start with the sleep problem rather than the clock. If your goal is occasional bedtime support, follow the exact product label. If you believe your body clock is shifted—because you cannot fall asleep until very late, are crossing time zones, or work an unusual schedule—the timing question becomes more complex.
A 2018 randomized trial in people with confirmed delayed sleep-wake phase disorder used 0.5 mg of fast-release melatonin one hour before each participant’s desired bedtime, together with behavioural sleep-wake scheduling. Sleep onset occurred earlier than with placebo. Other circadian studies use timing based on dim-light melatonin onset, a marker of biological night. Those protocols are not interchangeable with a 5 mg commercial tablet and should not be copied casually.
Does a 2-Minute Disintegration Test Mean It Works in 2 Minutes?
Dose and tablet disintegration are also different questions. Biogénique’s tested lot PK240514 had a disintegration result of 2 minutes against a specification of not more than 30 minutes. That is useful performance information about the tablet. It does not mean the product is absorbed in two minutes, reaches peak blood levels in two minutes, or makes someone fall asleep in two minutes.
Batch testing and clinical evidence answer different questions. Under Biogénique’s 3X PUR™ framework, disintegration can be discussed under Performance; microbial and heavy-metal results under Pureté; and tablet specifications under Qualité. For lot PK240514, the tested lot met the listed specifications. 3X PUR™ is Biogénique’s framework for interpreting the batch record, not a laboratory certification.
Light, Routine and the Signal You Send Your Body Clock
Timing melatonin well does not override basic sleep biology. Bright light late in the evening can work against the body’s natural night signal, while a consistent sleep-wake schedule helps anchor circadian timing. If you take melatonin and then spend the next hour under bright lights or scrolling in bed, you are adding a competing environmental signal.
A realistic routine is enough: choose a target bedtime, dim unnecessary light as it approaches, and keep wake time reasonably consistent. If sleep problems persist, the answer may be an underlying sleep, medical or behavioural issue rather than a timing tweak.
Biogénique Melatonin 5 mg: What the Current Label Says
Biogénique Melatonin is a 30-tablet product containing 5 mg of melatonin (N-acetyl-5-methoxytryptamine) per tablet, NPN 80063547. Its current label lists the recommended uses as helping re-set the body’s sleep-wake cycle and aiding relief of jet lag. For adults, the label directs one tablet once per day, at or before bedtime.
-
Do not drive or use machinery for 5 hours after taking melatonin.
-
For use beyond 4 weeks, consult a health care practitioner.
-
Do not use if pregnant or breastfeeding.
-
Keep out of reach of children and follow the full risk information on the label.
Lot PK240514: Quality Data Without Overclaiming
The current Drive COA for lot PK240514 lists manufacture in May 2024 and expiry in April 2027. The tablet’s weight result was 226.00 mg against a 225.00 mg ±5% specification; friability was 0.16%; hardness was 14 kgf; and disintegration was 2 minutes against a not-more-than-30-minute limit. Total plate count and yeast/mould were each reported below 10 CFU/g, the listed pathogens were negative, and arsenic, cadmium, lead and mercury were each reported below 0.001 µg/kg body weight/day against their respective specifications. The tested lot met the listed specifications.
|
3X PUR™ interpretation Pureté: the microbial, pathogen and heavy-metal results. Qualité: the tablet and physical specifications. Performance: the disintegration result. This is Biogénique’s framework for interpreting lot testing—not a certification issued by the laboratory, and not evidence that the tablet causes sleep within 2 minutes. |
Safety Still Matters After You Pick the Time
The Biogénique label says not to drive or use machinery for five hours after taking melatonin. Health Canada also advises avoiding alcohol and other products that cause drowsiness. People taking certain medications—including for seizures, blood pressure, immune suppression, mental state or sedation, steroids or blood thinners—or living with certain cardiovascular, immune, liver, kidney, seizure, asthma or diabetes conditions should speak with a health professional before use.
Do not use melatonin if pregnant or breastfeeding. If sleeplessness persists for more than four weeks, Health Canada advises consulting a health professional. In Canada, sleep-related melatonin use for people under 18 became prescription-only effective June 2, 2026, so this article is written for adults.
A Practical Timing Framework
Use this five-step check:
-
Define the target bedtime. “Before bed” only helps if bedtime is consistent enough to identify.
-
Follow the exact label. For Biogénique Melatonin 5 mg: one tablet once per day, at or before bedtime.
-
Give timing a fair test. Do not assume failure because you are not asleep within minutes.
-
Do not automatically re-dose. A once-daily product should not become multiple doses because the first one did not feel immediate.
-
Escalate the question, not the dose. If the problem looks like chronic insomnia, delayed sleep timing, shift-work disorder or repeated jet lag, a clinician or pharmacist can help assess timing.
Frequently Asked Questions
Can I take melatonin 2 or 3 hours before bed?
Not necessarily. Earlier schedules appear in research, especially when investigators are trying to shift circadian timing. But Biogénique’s label says at or before bedtime, and Health Canada’s current oral monograph gives 30 to 60 minutes before bedtime as the general direction. Do not turn a research protocol into a personal dosing plan without professional guidance.
Does 5 mg work faster than a lower dose?
No. A higher dose can increase exposure, but it does not guarantee faster onset. Pharmacokinetics vary among people, and formulation matters. More is not automatically faster or better.
Can I take melatonin at midnight?
If midnight is your intended bedtime, the label direction still applies. The bigger issue is whether midnight is consistent with the sleep schedule you are trying to maintain. A constantly moving bedtime can make results harder to interpret.
What if I wake up at 3 a.m.—can I take another tablet?
Do not automatically take another tablet in the middle of the night. Biogénique’s label directs one tablet once per day and warns against driving or operating machinery for five hours after use. Recurrent middle-of-the-night waking deserves a different evaluation than simply adding another dose.
Does the 2-minute COA disintegration result mean a 2-minute onset?
No. Lot PK240514 disintegrated in 2 minutes in the listed test, showing that the tablet broke apart rapidly under test conditions. Disintegration is not the same as absorption, peak melatonin concentration or time to fall asleep.
Bottom Line
For melatonin, timing is part of the mechanism. The simplest rule for Biogénique Melatonin 5 mg is to follow the product label: one tablet once daily, at or before bedtime. Health Canada’s broader monograph uses a 30-to-60-minute pre-bed window, while studies sometimes test earlier schedules for specific circadian problems. Those layers should not be collapsed into one universal rule. Start with the label, match the timing question to the sleep problem, and get professional guidance when the problem is persistent or clearly circadian.
Related Biogénique Resources
Evidence & Compliance Note
This article separates three evidence layers. (1) Biogénique licensed/product facts come from the current product label and NPN materials in Google Drive: 5 mg per tablet, 30 tablets, NPN 80063547, adult use once daily at or before bedtime, label uses, warnings and duration language. (2) Health Canada ingredient-level guidance comes from the current oral melatonin monograph and does not automatically expand Biogénique’s authorized product claims. (3) External studies explain pharmacokinetics and research timing; they are not presented as proof that Biogénique Melatonin produces the same outcome or should be used on the same schedule as a study product.
References
1. Melatonin - Oral Monograph. Health Canada, Natural and Non-prescription Health Products Directorate. Updated 19 Dec 2025. Source
2. Notice of amendment: pediatric melatonin. Health Canada. Sleep-related melatonin use under age 18 became prescription-only effective 2 Jun 2026. Source
3. Cruz-Sanabria F, et al.. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: systematic review and dose-response meta-analysis. Journal of Pineal Research. 2024;76(5):e12985. 26 double-blind RCTs; 1,689 observations. Source
4. Andersen LPH, et al.. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC Pharmacol Toxicol. 2016;17:8. Oral 10 mg study; mean Tmax about 40.8 minutes in 12 healthy male volunteers. Source
5. Moroni I, et al.. Pharmacokinetics of exogenous melatonin in relation to formulation, and effects on sleep: systematic review. Sleep Medicine Reviews. 2021;57:101431. Source
6. Sletten TL, et al.. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: double-blind randomized clinical trial. PLoS Med. 2018;15(6):e1002587. Source
7. Biogénique Melatonin 5 mg. Current product page. Product identity and website wording checked against Drive label/NPN materials. Source
8. Biogénique Quality Control. COA directory listing Melatonin 5 mg, NPN 80063547, lot PK240514. Source
9. Biogénique Products & Certification. Product form and NPN directory. Source
Disclaimer
This article is for general educational purposes and is not medical advice. Natural health products can interact with medications and may not be appropriate for everyone. Follow the product label and speak with a qualified health care professional when you have persistent sleep problems, take medications, have a medical condition, are pregnant or breastfeeding, or need individualized advice about melatonin timing.